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We analysed the incidence and etiological spectrum of acute symptomatic seizures in 2531 patients with seizure disorder, both
in-patients and out-patients, seen in a university hospital in South India. Seizure(s) occurred in close temporal association with
an acute systemic, metabolic, or toxic insult or in association with an acute central nervous system (CNS) insult in 22.5% of
patients. Of the 572 patients, 8% could be grouped under the International League Against Epilepsy (ILAE) category 4.1 and
92% under category 1.2. The seizure type was generalized in all the patients included in category 4.1 and 78% of patients
grouped in category 2.1 had simple or complex partial seizure(s) with or without secondary generalization. Sixteen (3%) patients
developed status epilepticus during the acute phase of illness and 7% of patients had only single seizure. Infections of the central
nervous system (CNS) and single CT enhancing lesions (SCTEL) together accounted for 77% of the provoking factors in patients
grouped under category 2.1. These two etiological factors together accounted for 95% of etiologies in patients aged under 16
years. SCTEL and neurocysticercosis together accounted for 67% of the provoking factors. In 14% of patients cerebrovascular
diseases were the etiological factors and 60% of the patients were aged over 40 years. In patients with cerebrovascular diseases,
aged under 40 years, cortical sinovenous thrombosis accounted for 37%. SCTEL was the provoking factor in 61% of patients
with isolated seizure. Infections of CNS and SCTEL together accounted for 62.5% of etiological factors for status epilepticus.
This study illustrates that the etiological spectrum of acute symptomatic seizures in this part of the world is different from
that described from developed countries and CNS infections account for a significant number of cases.
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cortical venous thrombosis.Introduction
Acute symptomatic seizures are those caused or pro-
voked by an acute medical or neurological illness1.
The incidence of acute symptomatic seizures have
only been reported in two epidemiologic studies. In
Rochester, Minnesota, the cumulative incidence of
acute symptomatic seizures in patients up to 80 years
of age is 3.7%2. A community-based study in the UK
reported that 21% of newly occurring seizures fell into
this category3. There are no such studies from devel-
oping countries and this study is aimed at determining
the incidence and etiological spectrum of acute symp-
tomatic seizure(s) in patients with seizure disorder seen
in a university hospital in South India.
Materials and Methods
All patients with seizure disorder, both in-patients and
out-patients, seen at Nizam’s Institute of Medical Sci-1059–1311/99/030162 + 04 $12.00/0ences, Hyderabad, between 1988 and 1994, formed
the study material. This institute is a university hos-
pital located in the capital city of Andhra Pradesh, a
province in South India and provides medical services
to a population of 26 089 0744. The etiology was con-
sidered acute symptomatic when seizure(s) occurred
in close temporal association with an acute systemic,
metabolic, or toxic insult or in association with an acute
central nervous system (CNS) insult. Guidelines pro-
posed by the Commission on Epidemiology and Prog-
nosis, International League Against Epilepsy (ILAE),
were considered while including patients with vari-
ous etiologies under acute symptomatic seizure(s)5.
All patients were diagnosed and classified using the
syndromic classification proposed by the International
League Against Epilepsy1. Patients with an isolated
seizure or status were grouped under symptomatic
localization-related epilepsy (1.2) when there was a
clear history of CNS insult known to be associated
with increased risk of seizures and also when therec© 1999 BEA Trading Ltd
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The likely etiology was determined by history, clinical
examination and appropriate investigations including
neuroimaging. Patients with seizure(s) due to a single
CT enhancing lesion (SCTEL) were included under
acute symptomatic seizures. SCTEL was defined as a
disc or ring lesion measuring less than 20 mm in size
and enhancing on contrast administration6, 7.
Results
Of the 2531 patients with various epilepsies and epilep-
tic syndromes seen during the study period, acute
symptomatic seizure(s) accounted for 22.5%. Forty-
six (8%) patients could be categorized under special
syndromes (4.1) and 526 (92%) patients under symp-
tomatic localization-related epilepsies (1.2) (Table 1).
Table 1: Acute symptomatic seizure(s).
Epileptic syndrome No. of patients
= 572/2531 (23%)
1. Localization-related epilepsies 526 (92)
1.2 Symptomatic —
Acute symptomatic 526
4. Special syndromes 46 (8)
4.1 Febrile seizures 30
Seizures due to acute metabolic 16
or toxic events
Seizure Type
The type of seizure, in patients categorized under 1.2,
was either simple partial or complex partial with or
without secondary generalization in 412 (78%) patients
and either unlocalized or generalized in 114 (22%) pa-
tients. Thirty-six (7%) patients had isolated seizure and
16 (3%) patients developed status epilepticus during
the acute phase of the illness. Generalized seizure was
the seizure type in all the patients included under cat-
egory 4.1.
Etiology
Of 46 patients in category 4.1, 30 had febrile seizures
and 16 had seizures in association with metabolic or
toxic encephalopathy.
In category 1.2, SCTEL was the provoking factor
in 50% of patients and infections of the CNS in 28%.
SCTEL and neurocysticercosis together accounted for
66% of the etiological factors. Neurotuberculosis was
the provoking factor in 83 (16%) patients. In 50 pa-
tients it was due to supratentorial tuberculomas and in
33 it was due to tuberculous meningitis. In 74 (14%)
patients seizures occurred within 7 days after a stroke(Table 2). CT showed multiple lesions in 63 (12%) pa-
tients (Table 3). SCTEL was the provoking factor in
61% of patients with isolated seizure. CNS infections
were the putative factors for status epilepticus in 62.5%
of patients (Table 4).
Table 2: Acute symptomatic localization-related epilepsy —
specific etiologies.
Etiology No. of patients .n D 526/ (%)
I. Vascular 74 (14)
Ischemic 32
Haemorrhagic 27
CSVT 15
II. SCTEL 262 (50)
III. Infections 145 (28)
Neurotuberculosis 83
Tuberculomas 50
Meningitis 33
Neurocysticercosis 50
Pyogenic meningitis 5
Abscess 3
Encephalitis 4
IV. Tumours 40 (7)
V. Others 5 (1)
CSVT, Cortical sinovenous thrombosis; SCTEL, single CT
enhancing lesion.
Table 3: Specific etiologies in patients in whom CT showed
lesions at multiple anatomical sites.
Etiology No. of patients
.n D 63/
Neurocysticercosis 50
Intracerebral haemorrhage 1
CSVT with multiple haemorrhagic infarcts 6
Tuberculous meningitis with multiple infarcts 4
Multiple tuberculoma 2
Table 4: Specific etiologies in patients with isolated seizure
and status epilepticus.
Etiology Isolated seizure Status epilepticus
.n D 36/ (%) .n D 16/ (%)
I. Infections 27 (75) 10 (62.5)
SCTEL 22 4
Neurotuberculosis 4 5
Encephalitis 1 1
II. Vascular 8 (22) 6 (37.5)
Ischemic 4 1
Haemorrhage 1 1
CSVT 3 4
III. Others 1 (3) –
SCTEL, Single CT enhancing lesion; CSVT, Cortical sinovenous
thrombosis.
SCTEL and CNS infections together accounted for
77% of etiological factors in patients aged under 40
years and in 95% of children aged under 16 years. Of
the patients who had experienced a stroke, 60% were
aged over 40 years. Cortical sinovenous thrombosis
(SCVT) accounted for 37% of strokes in patients aged
under 40 years (Table 5).
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groups.
Etiology Age group (yrs) P value
1–40 > 40
.n D 405/ .n D 121/
SCTEL 244 18 < 0:001
Infections of CNS 102 43 < 0:09
Cerebrovascular 30 44 < 0:001
diseases
Tumours 26 14 < 0:06
CNS, Central nervous system.
Discussion
Acute symptomatic seizures occur frequently and, in
the aggregate, are almost as common as febrile convul-
sions or epilepsy2. In the present study, acute symp-
tomatic seizures accounted for 22.5% of the total pa-
tient population studied. Similar incidence was re-
ported in a British community-based study of newly di-
agnosed epilepsy3. Provoked seizure(s) may be isolated
or recurrent8, 9. Patients with acute medical or neuro-
logical illness may present with status epilepticus10.
In the revised syndromic classification proposed by
the ILAE in 19891, seizures due to acute metabolic or
toxic factors and eclampsia fall into category 4.1 —
situational-related seizures. If seizures occur as a con-
sequence of a known or suspected disorder of the CNS,
they are considered to be symptomatic. The symp-
tomatic categories comprise syndromes of great indi-
vidual variability that are based mainly on seizure type,
anatomical localization and also etiology. The etiology
includes both acute and remote symptomatic seizures.
In patients in category 4.1, there is no underlying per-
manent brain damage; the seizures occurring in this
setting are usually self-limited. The primary consider-
ation in such patients should be the identification and
treatment of the underlying disorder. If antiepileptic
drugs are used to suppress acute seizures, they gener-
ally do not need to be continued after the patient has
recovered from the primary illness. Whereas in patients
with acute CNS insult each etiological factor is a sig-
nificant risk factor for both acute symptomatic seizures
and epilepsy. Although antiepileptic drugs are effective
in treating acute seizures, none has yet been shown to
delay or reduce the development of later epilepsy. How-
ever, the prognosis is substantially different when com-
pared to remote symptomatic epilepsy. In the British
National General Practice Study of Epilepsy9 after 9
years 93% (CI: 85–100) of patients with acute symp-
tomatic epilepsy achieved a 3-year remission, and 78%
(CI: 67–89) achieved a 5-year remission. The corre-
sponding rates for patients with remote symptomatic
epilepsy were 75% (CI: 62–97) and 61% (CI: 46–75).
The etiological spectrum of acute symptomatic
seizures seen in this study is different from that de-
scribed from Rochester, Minnesota2, 8. In the Rochesterstudy CNS infections accounted for about 15% of all
acute symptomatic seizures2, whereas in our study
CNS infections and SCTEL together accounted for
77% of etiological factors in patients grouped in the
ILAE category 1.2. The CNS-infection pattern fol-
lowed the pattern of infections in other tropical coun-
tries. Neurocysticercosis is a growing problem in trop-
ical countries and increasingly recognized as a leading
cause of epilepsy11–13. In India and in other countries
where neurocysticercosis is endemic, SCTEL is com-
mon in CT scans of patients with seizures6, 7, 14. His-
tological studies suggest that SCTEL represents dy-
ing cysticerci that will be spontaneously resolved as
the result of the host response14, 15. Seizures occur in
the acute encephalitic phase16, 17. Long-term follow-up
studies have shown that seizures cease to recur once the
lesion resolves on CT17. Tuberculous meningitis is the
most common type of chronic meningitis in India18.
In tuberculous meningitis seizures can occur at any
stage of the illness and may be the presenting feature.
Kennedy and Fallon19 reported that 10% of their stud-
ies of patients with tuberculous meningitis presented
with seizures. More than 60% of patients with intracra-
nial tuberculoma may have seizures20.
Seizures are common during the early phase after
a stroke and have been reported to occur with a fre-
quency of 2.5–5.7% within 14 days after a stroke21–25.
Some previous studies23, 26 but not others22, 24, 27 have
indicated relationship between early seizures in pa-
tients with intracerebral haemorrhage. In a recent study
Reith et al.25 have shown that the subtype of stroke
per se does not influence the risk of early seizures
and initial stroke severity is the sole predictor of early
seizures. Acute symptomatic seizures with stroke are
rare in persons less than 45 years of age, but the
incidence increases rapidly with increasing age2. In
this study stroke was the precipitating cause for acute
seizures in 30 patients aged 40 years and cortical
sinovenous thrombosis accounted for 37% of strokes.
Early seizures occurred with high frequency, 46–79%,
in many patients with cortical sinovenous thrombosis.
Seizures may be partial or generalized. Status epilepti-
cus and coma may ensue in some patients28–30. A num-
ber of conditions have been etiologically linked to cor-
tical sinovenous thrombosis. But in India the majority
of cases are related to pregnancy and purperium28, 29.
There is no difference in the frequency of acute symp-
tomatic seizures between puerperal and nonpuerperal
cortical sinovenous thrombosis31.
This study illustrates that the etiological spectrum
of acute symptomatic seizure(s) is different from that
described in developed countries and CNS infections
still account for a significant number of cases. Cortical
sinovenous thrombosis is an important cause of acute
symptomatic seizures among young patients with cere-
brovascular diseases.
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